Results 101 to 110 of about 355,585 (385)
A rapid glass‐substrate 3D microfabrication method creates anatomically accurate carotid artery‐on‐a‐chip models from stroke patient scans in 2 h. These miniaturized devices replicate patient‐specific blood vessel geometry and flow patterns, enabling real‐time imaging of clot formation under controlled injury.
Yunduo Charles Zhao +14 more
wiley +1 more source
Dental management of patients taking novel oral anticoagulants (NOAs): dabigatran [PDF]
A new group of oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years.
Albaladejo Martínez, Alberto +2 more
core +2 more sources
A Degradable Device for Sustainable Capillary Blood Sampling
The device features a compostable 3D‐printed storage compartment for liquid blood collection and a degradable, poly(ɛ‐caprolactone)‐coated magnesium microneedle patch hidden within a suction cup. Manual compression deploys the MNs, creating small skin punctures, and the subsequent release of compression generates the negative pressure required for ...
Nicole Zoratto +5 more
wiley +1 more source
BackgroundDespite higher thromboembolism risk, women with atrial fibrillation have lower oral anticoagulation (OAC) use compared to men. The influence of the CHA2DS2‐VASc score or the introduction of non–vitamin K OACs on this relationship is not known ...
Lauren E. Thompson +11 more
doaj +1 more source
Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M +36 more
core +1 more source
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Novel oral anticoagulants (NOACs), which include direct thrombin inhibitor (dabigatran) and direct factor Xa inhibitors (rivaroxaban, apixaban and edoxaban), are gaining popularity in the prevention of embolic stroke in non-valvular atrial fibrillation ...
K. Cheung, W. Leung
semanticscholar +1 more source
Research Progress in Wearable Microneedle Sensors for Health Analysis
Wearable biosensors are transforming personal healthcare by enabling minimally invasive, molecular‐level monitoring. Emerging electrochemical microneedle sensors can detect analytes in interstitial fluid, enabling painless extraction and real‐time tracking.
Adnan Zameer +3 more
wiley +1 more source
Background Anticoagulation in patients with malignancy and atrial fibrillation is challenging because of enhanced risks for thrombosis and bleeding and the frequent need for invasive procedures. Data on direct oral antagonists in such patients are sparse.
Christina L. Fanola +11 more
doaj +1 more source
Antithrombotic agents, including antiplatelet agents and anticoagulants, are increasingly used in South Korea. The management of patients using antithrombotic agents and requiring gastrointestinal endoscopy is an important clinical challenge.
Hyun Lim +12 more
doaj +1 more source
Type of atrial fibrillation and clinical outcomes in patients with heart failure and reduced ejection fraction [PDF]
Background: Atrial fibrillation (AF) is common in heart failure (HF), but the outcome by type of AF is largely unknown. Objectives: This study investigated outcomes related to type of AF (paroxysmal, persistent or permanent, or new onset) in 2 ...
Abraham, William T. +11 more
core +3 more sources

